Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-139079
Filing Date
2024-12-20
Accepted
2024-12-20 16:30:07
Documents
2
Period of Report
2024-12-16

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1574
2 EX-24 aktx-ex24.htm EX-24 13013
  Complete submission text file 0000950170-24-139079.txt   16173
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Issuer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 529 W 42ND ST #6V NEW YORK NY 10036
Business Address
Hombeck Torsten (Reporting) CIK: 0001983682 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36288 | Film No.: 241568364